Navigation Links
New Innovation for Battling Number One Killer in America Introduced by Eniva Nutraceutics
Date:2/28/2009

MINNEAPOLIS, Feb. 28 /PRNewswire/ -- In its ongoing contribution to science and the innovation of industry leading nutraceuticals, Eniva Nutraceutics announces the introduction of its new Eniva(R) Cholesterol Reducer(TM) formula. This advanced, liquid nutritional supplement is Eniva's newest heart health product, designed to support healthy cholesterol and homocysteine levels in the body.*

The potent cholesterol lowering plant sterol formulation in the Eniva Cholesterol Reducer meets the requirements of the US Food and Drug Administration for potentially reducing the risk of heart disease. The claim states: Supplements containing at least 0.4 grams per serving of plant sterols, eaten twice a day with meals for a daily total intake of at least 0.8 grams, as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. One serving daily of Eniva Cholesterol Reducer contains 0.8 grams of phytosterols.

Statistics show one in three Americans have cholesterol levels that put them at risk for heart disease, with many people unaware their levels are high. Elevated cholesterol contributes to unwanted plaque build-up in blood vessels, which in turn leads to complications associated with heart disease. According to the American Heart Association (AHA), heart disease is currently the number one killer in America. Eniva Cholesterol Reducer is the only liquid supplement on the market that offers high concentration plant sterols as well as a high-dose vitamin blend to address two major risk factors for heart disease -- cholesterol and homocysteine.* Homocysteine is another substance present in blood that is recognized by the AHA to be unhealthy for blood vessels when elevated.

Research has shown the ingestion of plant based materials, called phytosterols, in appropriate levels and dosing patterns, can help reduce cholesterol levels in the body and may reduce the risk of heart disease when combined as part of a diet low in saturated fat and cholesterol.** The Eniva Cholesterol Reducer contains a specialized and proprietary formula of clinically proven plant sterols at a concentration shown to reduce cholesterol levels in clinical studies.** Its liquid formulation ensures proper dissolution and dispersion of the cholesterol fighting phytosterols, a key factor for effectiveness of these nutrients. Also contained in the formula are threshold levels of selective nutrients shown in clinical studies to assist in body processing of homocysteine.*

Designed and formulated by Eniva Chief Medical Officer Benjamin Baechler, MD, this advanced innovation can be taken alone or in conjunction with an already established care plan. Stated Dr. Baechler, "Many people are currently taking statin medications to address cholesterol concerns. The Eniva Cholesterol Reducer is a safe and natural option to help individuals fight cholesterol, and it can be used in conjunction with statin medications as part of a complementary wellness plan.* "

Andrew Baechler, Eniva CEO, emphasized the company's dedication to ongoing innovation. "People are looking for creative ways to win with their health. This great tasting, liquid supplement with proven ingredients to promote heart health, is a real breakthrough not only for Eniva, but for all people battling cholesterol.*"

Added Dr. Baechler, "The best route to combat heart and blood vessel issues is through healthy lifestyle choices and regular doctor visits with appropriate guidance. In combination with this, the Eniva Cholesterol Reducer can be part of an effective program to help keep the heart and blood vessels healthy.** However, as with all dietary supplements, Eniva Nutraceutics recommends that individuals first check with their personal qualified health care provider before beginning any dietary supplement."

All ingredients in the Eniva Cholesterol Reducer have been evaluated and are listed on the United States FDA's G.R.A.S. (Generally Regarded As Safe) governmental listing.

Eniva Corporation, located in Minneapolis, MN, designs, manufactures and distributes concentrated liquid nutritional supplements and other body support products. Founded in 1998, Eniva has earned the distinction of being the pioneer of advanced liquid nutraceutical products and innovative nutrient delivery systems. For more information, visit www.enivawc.com.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

** Supplements containing at least 0.4 grams per serving of plant sterols, eaten twice a day with meals for a daily total intake of at least 0.8 grams, as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. One serving daily of Eniva Cholesterol Reducer contains 0.8 grams of phytosterols.


'/>"/>
SOURCE Eniva Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Stem Cell Innovations C3A Human Liver Cell Line is Capable of Producing Biosimilar Serum Proteins for Follow-On Biologics
2. Case Western Reserve University faculty named 2009 NorTech Innovation Award winner
3. Inverness Medical Innovations Announces Fourth Quarter 2008 Results
4. BMP Sunstone Reiterates Commitment to Quality, Innovation and Long-Term Growth at Meeting with Senior Officials
5. Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation
6. NorTech, Crains Cleveland Business Honor 2009 Innovation Award Winners
7. MEDRAD Molecular Imaging Earns Top Rank in Innovation
8. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 18, 2009 to Discuss Fourth Quarter 2008 Results
9. Samplify Systems SAM1600 Family of Analog/Digital Converters Named Finalist in EDN Magazines 19th Annual Innovation Awards
10. James Roosevelt, Jr. Joins Inverness Medical Innovations Board of Directors
11. Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Orion, Clarkston Michigan (PRWEB) , ... May 24, ... ... new Certified Nurse Midwife, Roberta Jordan. , Roberta Jordan is a Certified ... degree from Grand Valley State University and then went on to complete her ...
(Date:5/24/2016)... Indianapolis, IN (PRWEB) , ... May 24, 2016 ... ... employee benefits advisory organization, is pleased to welcome new Partner Firm Austin & ... a personalized, consultative approach to insurance, employee benefits, HR consulting, benefits technology, and ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... Center at Sentara Northern Virginia Medical Center located in Woodbridge, VA. The ... surgical services into a single site. , The new 2 story building houses ...
(Date:5/24/2016)... ... May 24, 2016 , ... Mental health watchdog Citizens Commission on Human ... renowned professor of psychiatry Thomas Szasz, is continuing its protest against the use of ... exhibit in Atlanta, Georgia. The opening of the exhibit follows CCHR’s recent protest at ...
(Date:5/24/2016)... ... May 24, 2016 , ... Loma Linda University Health ... adult hospital and expanded Children’s Hospital. Over 3,000 people looked on as the shovels ... out the event photo slidehsow. , During the program, Richard H. Hart, MD, ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... May 23, 2016 Non-invasive diagnostic ... of multiple diseases; ,Technology to be presented at Yissum’s ... Yissum Research Development Company of the Hebrew University of ... research agreement with Aurum Ventures MKI, the technology investment arm ... a new diagnostic approach for early detection of multiple ...
(Date:5/22/2016)... May 23, 2016 DS ... anti-fibrotic and anti-inflammatory compound DS102 in chronic obstructive ... non-alcoholic steatohepatitis (NASH) patients. Recent DS ... in lung tissue and has bronchodilatory, anti-inflammatory and ... administration. The Company will publish further detail on ...
(Date:5/20/2016)... ReportsnReports.com adds "Plaque Psoriasis ... research report with comprehensive information on the therapeutic ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
Breaking Medicine Technology: